Article in Protein science : a publication of the Protein Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
CaProtein science : a publication of the Protein Society · 2022
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 3 institutions in 1 country.
Garry E SmithVoiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, Washington, USA.ORCID 0000-0001-9544-0938
Dmitri TolkatchevVoiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, Washington, USA.ORCID 0000-0002-1300-6458
Cristina RisiDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Madison LittleVoiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, Washington, USA.
Carol C GregorioDepartment of Cellular and Molecular Medicine and Sarver Molecular Cardiovascular Research Program, University of Arizona, Tucson, Arizona, USA.
Vitold E GalkinDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Alla S KostyukovaVoiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, Washington, USA.ORCID 0000-0002-6724-2069
Washington State University · USEastern Virginia Medical School · USUniversity of Arizona · US
Funding
TRAINING IN BIOTECHNOLOGY: EMPHASIS ON PROTEIN CHEMISTRYT32GM008336 · NIGMS · WASHINGTON STATE UNIVERSITY · PI CALL, DOUGLAS R. · 1989 to 2023
$8.9M
Deciphering the role of Lmod2 in thin filament length regulation and dilated cardiomyopathyR01HL123078 · NHLBI · UNIVERSITY OF ARIZONA · PI Carol C Gregorio, Shashank Shekhar · 2015 to 2026
$5.6M
REGULATION OF THE ACTIN FILAMENT POINTED END DYNAMICS IN HEALTH AND DISEASER01GM120137 · NIGMS · WASHINGTON STATE UNIVERSITY · PI GALKIN, VITOLD, GREGORIO, CAROL C · 2017 to 2024
ActinsTropomodulinActin CytoskeletonMuscle ContractionTroponinActinsTropomodulinTroponinactincircular dichroismleiomodinnuclear magnetic resonancepyrene-actin polymerizationtransmission electron microscopy
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.